Examining the frequency of bloodstream infection in these patients, researchers have found that staphylococcus aureus is most prevalent, followed by Klebsiella and E. coli.
One in 5 patients with febrile neutropenia experience bloodstream infection, which often results in mortality and highlights the importance of awareness of prevalent pathogens and their susceptibility pattern for effective treatment of infection. Examining the frequency of bloodstream infection in these patients, researchers have found that staphylococcus aureus is most prevalent, followed by Klebsiella and E. coli.
Between February 21, 2016, and August 20, 2017, the researchers observed 200 patients over age 15 with severe neutropenia. Each patient had 4 to 5 ml of venous blood taken, which was sent to the laboratory within 20 minutes of collection, and antimicrobial sensitivity testing of all isolates were performed on diagnostic sensitivity test plates.
According to the researchers, Staphylococcus aureus was identified as round grape-like colonies under the microscope; Pseudomonas aeruginosa was identified as rod-shaped bacteria with unipolar motility; E. coli was identified as rod-shaped and 2 mm long and 0.5 μm in diameter; and Klebsiella pneumonae was identified as small rod-shaped structures inoculated in culture.
During the study period, 89 patients (44.5%) had low-grade fever and 111 (55.5%) had high-grade fever. The frequency of Staphylococcus aureus was 16%, E. coli was 14.5%, Pseudomonas aeruginosa was 8.5%, and Klebsiella pneumonae was 15.5%.
Staphylococcus aureus (19.2% vs 11.3%) was more common in men than in women, while Pseudomonas aeruginosa (10% vs 7.5%), E. coli (15% vs 14.2%), and Klebsiella pneumonae (17.5% vs 14.2%) were more common in women than in men.
“Thirty years ago most of the infections in these patients were caused by aerobic Gram-negative bacilli. Over the last 20 years, however, a shift in the bacterial spectrum towards Gram-positive cocci has been reported in the west,” wrote the researchers. “Although the exact cause of this shift is not known, long-dwelling intravascular devices, fluoroquinolone prophylaxis, and chemotherapy-induced mucositis have been implicated.”
Reference
Siddiqui B, Azmat R, Tikmani S, et al. Frequency of bloodstream infection in febrile neutropenic patients, experience from a developing country [published September 12, 2018]. Ann Med Surg. doi: 10.1016/j.amsu.2018.09.004.
The Long-term Social Value of Granulocyte Colony-Stimulating Factors
October 4th 2019Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Read More
Patients with hematologic malignancy who are undergoing chemotherapy or a conditioning regimen for hematopoietic stem cell transplant (HSCT) are at high risk of infection because of the severity and duration of neutropenia. Fever with neutropenia is a common presentation that suggests an infection leading to empiric antibacterial therapy. To prevent infection and thus the neutropenic fever, antibacterial prophylaxis, especially with fluoroquinolones, emerged as a common practice based on results of 2 randomized controlled trials published in 2005 that showed reduced incidence of fever and bacteremia despite lack of a mortality benefit.
Read More
Neutropenia Etiology Influences Resulting Hematologic Consequences
March 2nd 2019Hematological consequences of severe chronic neutropenia vary based on the underlying etiology of the condition, according to a study abstract presented at the 60th American Society of Hematology Annual Meeting & Exposition.
Read More
Home Monitoring Device for Blood Cell, Neutrophil Counts Shows Positive Initial Results
February 22nd 2019Initial results of a study have found that white blood cell counts and absolute neutrophil counts, which are well-established predictors of risk of infections or febrile neutropenia, can be accurately measured with a finger stick drop of blood and point-of-care hematology results.
Read More